透射超声定量乳腺组织构成与MRI对照验证研究
本研究回顾性纳入29名女性的53只乳房,比较定量透射(QT)超声与MRI在纤维腺体组织体积(FGV)及纤维腺体比例(FGR)测量中的一致性。结果显示两者强相关(FGV r=0.893,FGR r=0.915),平均偏倚分别为-13.2 cm³和+12.7%,支持QT作为临床乳腺密度定量评估工具的可行性。
要点
- QT超声可定量FGV和FGR,与MRI强相关(FGR r=0.915),可用于乳腺密度评估
- QT与MRI间存在系统偏差(FGV偏倚-13.2 cm³,FGR偏倚+12.7%),阅片时需注意
- QT技术已获FDA批准用于FGR测量,可作为MRI的替代方案
核心结论
- QT技术能够准确、可重复地定量乳腺纤维腺体组织体积和比例,与MRI强相关(FGV r=0.893,FGR r=0.915,p<0.0001),支持其作为临床乳腺密度定量成像生物标志物
研究设计与样本
- 回顾性分析,来自ACC RUE研究(NCT03052166),共29名女性的53只乳房
- QT扫描使用QT Scanner 2000 Model A,通过全波逆散射算法重建三维声速图和反射图
- MRI作为参考标准,采用验证过的模板法分割
- QT数据使用模糊C均值分割计算FGV和FGR
- 统计方法包括Pearson相关、组内相关系数(ICC)和Bland-Altman分析
关键影像表现/征象
- QT与MRI测量的FGV呈强相关(r=0.893)
- QT与MRI测量的FGR呈强相关(r=0.915,p<0.0001)
- FGV平均偏倚为-13.2 cm³(QT低于MRI)
- FGR平均偏倚为+12.7%(QT高于MRI)
- 回归斜率分别为0.63(FGV)和1.35(FGR),两者均存在显著比例偏倚(p<0.0001)
诊断标准与关键数值
- QT测FGV与MRI相关系数r=0.893
- QT测FGR与MRI相关系数r=0.915(p<0.0001)
- FGV平均偏倚-13.2 cm³,FGR平均偏倚+12.7%
- 回归斜率:FGV为0.63,FGR为1.35,均p<0.0001
临床应用与阅片要点
- QT超声可作为MRI的替代方法定量乳腺密度,适用于有MRI禁忌或资源受限场景
- QT测得的FGR系统偏高,报告时应考虑该偏倚,或建立中心校正值
- QT测FGV系统偏低,定量评估时需注意与MRI结果的差异
局限性
- 回顾性研究设计
- 样本量有限(仅53只乳房)
- 单中心数据(ACC RUE研究)
- QT与MRI的场视野定义不同可能造成系统差异
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Accurate quantification of fibroglandular tissue volume (FGV) and the fibroglandular ratio which is the ratio of FGV to the total breast volume (TBV) (FGR = FGV/TBV) is critical for assessment of a patient's lifetime breast cancer risk and personalized screening strategies. Magnetic resonance imaging (MRI) is considered the research standard for volumetric breast composition analysis but is limited by cost, availability, and contraindications. This study evaluates the capability of quantitative transmission (QT) imaging technology to measure FGV and FGR and compares these results with MRI-derived metrics, establishing quantitative equivalence between the two modalities.
MATERIALS AND METHODS: A retrospective analysis included 53 breasts from 29 women imaged using QT scan and MRI within 30 days as part of the ACCRUE Study (ClinicalTrials.gov NCT03052166). QT data were acquired with the QT Scanner 2000 Model A and reconstructed into 3D speed-of-sound maps and respective reflection maps via a full-wave inverse scattering algorithm. FGV and FGR were computed using a fuzzy c-means segmentation as applied to the quantitative tissue maps. MRI datasets were segmented using a validated template-based method. Statistical comparisons included Pearson correlation (r), intraclass correlation coefficient (ICC), and Bland-Altman analysis.
RESULTS: QT and MRI measurements demonstrated strong correlations for both FGV (r = 0.893) and FGR (r = 0.915, p < 0.0001). Mean biases were -13.2 cm³ for FGV and +12.7% for FGR. Regression slopes were 0.63 and 1.35, respectively, with significant proportional bias for both (p < 0.0001). Systematic differences were consistent with modality-specific contrast mechanisms and field-of-view definitions; the strong correlation and stable, predictable bias support quantitative concordance between the modalities.
CONCLUSION: QT technology provides accurate, reproducible, and volumetric quantification of breast fibroglandular tissue, demonstrating strong concordance with MRI. These results supported FDA clearance of the QT FGR feature, establishing it as a validated quantitative imaging biomarker for clinical breast density assessment.
引用
- Malik, Chen, Su, et al. Volumetric Quantification of Breast Tissue Composition Using Transmission Ultrasound: A Validation Study Against MRI. Ultrasound Med Biol. 2026. PMID: 42595593. doi:10.1016/j.ultrasmedbio.2026.07.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。